Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12268831
Swallowable drug delivery device and methods of drug delivery
granted -
US 12268700
3-o-sulfo-galactosylceramide analogs as activators of type II NKT cells and uses thereof
granted -
US 12269888
Artificial cell death polypeptide for chimeric antigen receptor and uses thereof
granted -
US 12269860
Compositions and methods comprising engineered chimeric antigen receptor and modulator of CAR
granted -
US 12269872
Neutralizing antibodies to Plasmodium falciparum circumsporozoite protein and their use
granted -
US 12269858
Activin receptor type IIB variants and methods of use thereof
granted -
US 12269805
Inhibitors of platelet function and methods for use of the same
granted -
US 12268737
Stabilized influenza hemagglutinin stem region trimers and uses thereof
granted -
US 12268720
Bacteriophage for treatment and prevention of E. coli and B. fragilis infections
granted -
US 12269856
Hepcidin analogues and uses thereof
granted -
US 12269887
Anti-canine CD16 polypeptides, anti-canine CD64 polypeptides, compositions including same, and methods of using
granted -
US 12269886
Tetravalent bispecific antibody against PD-1 and PD-L1
granted -
US 12269801
Modified amino acids
granted -
US 12269155
Multivalent vaccines for rabies virus and coronaviruses
granted -
US 12269808
Amino dithioperacid thioester compound, preparation method therefor, and use thereof
granted -
US 12269820
Piperazine substituted indazole compounds as inhibitors of PARG
granted -
US 12268730
Use of a VEGF antagonist to treat angiogenic eye disorders
granted -
US 12269831
Modulators of cystic fibrosis transmembrane conductance regulator
granted -
US 12268753
Nanomaterials comprising a biodegradable feature
granted -
US 12268749
Cell-penetrating peptides
granted -
US 12268693
Pharmaceutical compositions comprising a tolfenamic acid
granted -
US 12268683
Compounds and methods for synergistic activation of M channels
granted -
US 12268694
Combination pharmaceutical agents as RSV inhibitors
granted -
US 12270080
NcRNA and uses thereof
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.